This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Pew Commends Senators Gillibrand And Feinstein For Working To Shine Light On Antibiotics Practices

Senate HELP Committee Bill Omits Data Reporting

WASHINGTON, March 20, 2013 /PRNewswire-USNewswire/ -- The Senate Health, Education, Labor and Pensions Committee today adopted the Animal Drug User Fee Act, which failed to include provisions from Senators Kirsten Gillibrand (D-NY) and Dianne Feinstein (D-CA) that would improve the Food and Drug Administration's annual reporting of antibiotic sales for use on industrial farms. The following statement should be attributed to Laura Rogers, project director, The Pew Charitable Trusts.

"We are extremely disappointed with the Senate HELP Committee. Though it is charged with protecting the public's health, it failed to seize its best opportunity to shine more light on practices that are breeding drug-resistant bacteria. These 'superbugs' make infections more difficult and costly to treat and more likely to cause death. Without greater transparency, antibiotic overuse may continue unchecked.

"We applaud Senators Kirsten Gillibrand (D-NY) and Dianne Feinstein (D-CA) for leading the way on this issue. Their proposal to increase the transparency of antibiotic use on industrial farms would have shed much needed light on practices that threaten our health. The Animal Drug User Fee Act is our best chance to address this challenge, and we will work with them as the bill moves to the Senate floor to ensure that we do not miss this opportunity."

The Pew Charitable Trusts is driven by the power of knowledge to solve today's most challenging problems. Pew applies a rigorous, analytical approach to improve public policy, inform the public and stimulate civic life.

SOURCE The Pew Charitable Trusts

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs